Press Releases :: Graphite Bio, Inc. (GRPH)

Jan 27, 2022 8:00am EST

Graphite Bio Announces Participation in Upcoming Investor Conferences

Dec 11, 2021 9:00am EST

Graphite Bio Presents Overview of Phase 1/2 CEDAR Trial Evaluating Investigational Gene Editing Therapy GPH101 in Sickle Cell Disease at 63rd ASH Annual Meeting and Exposition

Dec 07, 2021 8:00am EST

Graphite Bio to Host Key Opinion Leader Webinar on Gene Correction for Sickle Cell Disease

Nov 17, 2021 8:00am EST

Graphite Bio Enrolls First Patient in Phase 1/2 Clinical Trial of GPH101 for Sickle Cell Disease

Nov 10, 2021 4:05pm EST

Graphite Bio Reports Recent Business Progress and Third Quarter 2021 Financial Results

Nov 04, 2021 9:13am EDT

Graphite Bio Announces Presentation on Phase 1/2 CEDAR Trial of GPH101 in Sickle Cell Disease at Upcoming 63rd ASH Annual Meeting and Exposition

Oct 21, 2021 8:00am EDT

Graphite Bio Announces Participation in Upcoming Jefferies Gene Therapy/Editing Summit

Oct 12, 2021 1:00pm EDT

Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention

Oct 05, 2021 8:00am EDT

Graphite Bio Announces Upcoming Presentation at 49th Annual Sickle Cell Disease Association of America National Convention

Aug 30, 2021 8:00am EDT

Graphite Bio Announces Participation in Upcoming September Investor Conferences

rss_feed News RSS

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Graphite Bio, its subsidiaries or affiliates. No use of any Graphite Bio trademark, trade name, or trade dress in this site may be made without the prior written authorization of Graphite Bio, except to identify the product or services of the company.

©Copyright 2021 Graphite Bio, Inc. All rights reserved.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Advertisement

Others